Coutilisation of oral rehydration solution and zinc for treating diarrhoea and its associated factors among under-five children in East Africa: a multilevel robust Poisson regression.
Autor: | Legesse BT; Department of Pediatrics and Neonatal Nursing, Wollega University, Nekemte, Ethiopia brucktesfaye143@gmail.com., Wondie WT; Department of Pediatrics and Child Health Nursing, Ambo University College of Medicine and Public Health, Ambo, Ethiopia., Gedefaw GD; Department of Neonatal Health Nursing, University of Gondar College of Medicine and Health Sciences, Gondar, Ethiopia., Workineh YT; Department of Pediatrics and Child Health Nursing, Wolaita Sodo University, Sodo, Ethiopia., Seifu BL; Department of Public Health, College of Medicine and Health Sciences, Samara University, Samara, Ethiopia. |
---|---|
Jazyk: | angličtina |
Zdroj: | BMJ open [BMJ Open] 2024 Mar 07; Vol. 14 (3), pp. e079618. Date of Electronic Publication: 2024 Mar 07. |
DOI: | 10.1136/bmjopen-2023-079618 |
Abstrakt: | Objective: This study aimed to assess the coutilisation of oral rehydration solution (ORS) and zinc for treating diarrhoea and its associated factors among under-5 children in East Africa. Design: Cross-sectional study design. Multilevel Poisson regression analysis with robust variance was fitted to identify predictors of zinc and ORS coutilisation. An adjusted prevalence ratio (aPR) with a 95% CI was reported to declare the statistical significance. Setting: Twelve East African countries. Participants: 16 850 under-5 children who had diarrhoea were included in the study. Result: In East African nations, the coutilisation of ORS and zinc for the treatment of diarrhoea in children under 5 was 53.27% with a 95% CI (52.54% to 54.01%). Children of mothers with primary education (aPR 1.15, 95% CI 1.09 to 1.20), secondary education (aPR 1.08, 95% CI 1.02 to 1.14), higer education (aPR 1.19, 95% CI 1.10 to 1.29), those from maternal age category of 20-24 (aPR 1.14, 95% CI 1.07 to 1.21), age category of 25-29 (aPR 1.13, 95% CI 1.06 to 1.21), age category of 30-34 (aPR 1.09, 95% CI 1.02 to 1.16), those from wealthy households (aPR 1.04, 95% CI 1.01 to 1.09) and those who have a media exposure (aPR 1.04, 95% CI 1.01 to 1.08) were more likely to receive combination. Conclusion: Only half of the under-5 children with diarrhoea in East Africa were treated with a combination of ORS and zinc. To increase the use of the suggested combination therapy of ORS with zinc, it is important to empower women through education and prevent teen pregnancy. Competing Interests: Competing interests: None declared. (© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ.) |
Databáze: | MEDLINE |
Externí odkaz: |